I. Lager

2.5k total citations
40 papers, 1.9k citations indexed

About

I. Lager is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, I. Lager has authored 40 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Endocrinology, Diabetes and Metabolism, 13 papers in Surgery and 13 papers in Molecular Biology. Recurrent topics in I. Lager's work include Diabetes Management and Research (23 papers), Metabolism, Diabetes, and Cancer (11 papers) and Diabetes Treatment and Management (10 papers). I. Lager is often cited by papers focused on Diabetes Management and Research (23 papers), Metabolism, Diabetes, and Cancer (11 papers) and Diabetes Treatment and Management (10 papers). I. Lager collaborates with scholars based in Sweden, Denmark and Germany. I. Lager's co-authors include Ulf Smith, J. Fowelin, Stig Attvall, H. von Schenck, Bengt‐Åke Bengtsson, G. Blohmé, Kerstin Landin‐Wilhelmsen, Per Johansson, Lars Steen and Kerstin Berntorp and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

I. Lager

39 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I. Lager Sweden 20 1.4k 524 441 392 375 40 1.9k
M. Nattrass United Kingdom 26 1.1k 0.8× 452 0.9× 536 1.2× 242 0.6× 450 1.2× 125 2.1k
J. Fowelin Sweden 15 990 0.7× 483 0.9× 198 0.4× 334 0.9× 225 0.6× 23 1.4k
James M. Falko United States 25 933 0.7× 322 0.6× 515 1.2× 253 0.6× 230 0.6× 76 1.7k
Theodora Temelkova‐Kurktschiev Germany 22 1.3k 1.0× 351 0.7× 262 0.6× 541 1.4× 469 1.3× 47 2.1k
M. Oleggini Italy 9 1.1k 0.8× 880 1.7× 332 0.8× 703 1.8× 387 1.0× 17 2.3k
L Graziadei Italy 8 1.1k 0.8× 750 1.4× 247 0.6× 730 1.9× 346 0.9× 14 2.1k
R.J. Heine Netherlands 22 920 0.7× 310 0.6× 264 0.6× 256 0.7× 363 1.0× 40 1.6k
Jan Lysgaard Madsen Denmark 14 1.1k 0.8× 468 0.9× 962 2.2× 159 0.4× 433 1.2× 31 2.2k
Ralph A. DeFronzo United States 20 578 0.4× 749 1.4× 371 0.8× 224 0.6× 595 1.6× 23 1.8k
Elizabeth B. Rappaport United States 16 757 0.6× 267 0.5× 224 0.5× 219 0.6× 843 2.2× 26 1.7k

Countries citing papers authored by I. Lager

Since Specialization
Citations

This map shows the geographic impact of I. Lager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Lager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Lager more than expected).

Fields of papers citing papers by I. Lager

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Lager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Lager. The network helps show where I. Lager may publish in the future.

Co-authorship network of co-authors of I. Lager

This figure shows the co-authorship network connecting the top 25 collaborators of I. Lager. A scholar is included among the top collaborators of I. Lager based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Lager. I. Lager is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lind, Marcus, Johan Jendle, Ole Torffvit, & I. Lager. (2011). Glucagon-like peptide 1 (GLP-1) analogue combined with insulin reduces HbA1c and weight with low risk of hypoglycemia and high treatment satisfaction. Primary care diabetes. 6(1). 41–46. 67 indexed citations
2.
Alvarsson, Michael, G. Sundkvist, I. Lager, et al.. (2007). Effects of insulin vs. glibenclamide in recently diagnosed patients with type 2 diabetes: a 4‐year follow‐up. Diabetes Obesity and Metabolism. 10(5). 421–429. 44 indexed citations
3.
Alvarsson, Michael, G. Sundkvist, I. Lager, et al.. (2003). Beneficial Effects of Insulin Versus Sulphonylurea on Insulin Secretion and Metabolic Control in Recently Diagnosed Type 2 Diabetic Patients. Diabetes Care. 26(8). 2231–2237. 127 indexed citations
4.
Madsbad, Sten, et al.. (2001). Comparison between repaglinide and glipizide in Type 2 diabetes mellitus: a 1‐year multicentre study. Diabetic Medicine. 18(5). 395–401. 49 indexed citations
5.
Hermann, L. S., et al.. (2001). Long‐term glycaemic improvement after addition of metformin to insulin in insulin‐treated obese type 2 diabetes patients. Diabetes Obesity and Metabolism. 3(6). 428–434. 27 indexed citations
6.
Johansson, Per, J. Fowelin, Kerstin Landin‐Wilhelmsen, I. Lager, & Bengt‐Åke Bengtsson. (1995). Growth hormone-deficient adults are insulin-resistant. Metabolism. 44(9). 1126–1129. 239 indexed citations
7.
Fowelin, J., Stig Attvall, H. von Schenck, Ulf Smith, & I. Lager. (1995). Characterization of the Insulin‐antagonistic Effect of Growth Hormone in Insulin‐dependent Diabetes Mellitus. Diabetic Medicine. 12(11). 990–996. 16 indexed citations
8.
Fowelin, J., Stig Attvall, H. von Schenck, et al.. (1994). Regulation of insulin-like growth factor binding protein-1 (IGFBP-1) in insulin-dependent diabetes mellitus. Acta Diabetologica. 31(4). 183–186. 9 indexed citations
9.
Fowelin, J., Stig Attvall, I. Lager, & Bengt‐Åke Bengtsson. (1993). Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency. Metabolism. 42(11). 1443–1447. 167 indexed citations
10.
Fowelin, J., Stig Attvall, H. von Schenck, et al.. (1993). Effect of prolonged hyperglycemia on growth hormone levels and insulin sensitivity in insulin-dependent diabetes mellitus. Metabolism. 42(3). 387–394. 15 indexed citations
11.
Attvall, Stig, J. Fowelin, I. Lager, H. von Schenck, & Ulf Smith. (1993). Smoking induces insulin resistance—a potential link with the insulin resistance syndrome. Journal of Internal Medicine. 233(4). 327–332. 314 indexed citations
12.
Attvall, Stig, J. Fowelin, H. von Schenck, Ulf Smith, & I. Lager. (1992). Insulin-antagonistic effects of pulsatile and continuous glucagon infusions in man--a comparison with the effect of adrenaline.. The Journal of Clinical Endocrinology & Metabolism. 74(5). 1110–1115. 12 indexed citations
13.
Fowelin, J., Stig Attvall, H. von Schenck, Ulf Smith, & I. Lager. (1991). Characterization of the insulin-antagonistic effect of growth hormone in man. Diabetologia. 34(7). 500–506. 83 indexed citations
14.
Fowelin, J., Stig Attvall, H. von Schenck, Ulf Smith, & I. Lager. (1990). Characterization of the late posthypoglycemic insulin resistance in insulin-dependent diabetes mellitus. Metabolism. 39(8). 822–826. 3 indexed citations
15.
Fowelin, J., Stig Attvall, H. von Schenck, Ulf Smith, & I. Lager. (1990). Postprandial Hyperglycaemia Following a Morning Hypoglycaemia in Type 1 Diabetes Mellitus. Diabetic Medicine. 7(2). 156–161. 7 indexed citations
16.
Smith, Ulf & I. Lager. (1989). Insulin‐antagonistic effects of counterregulatory hormones: Clinical and mechanistic aspects. Diabetes/Metabolism Reviews. 5(6). 511–525. 13 indexed citations
17.
Attvall, Stig, J. Fowelin, H. von Schenck, I. Lager, & Ulf Smith. (1987). Insulin resistance in Type 1 (insulin-dependent) diabetes following hypoglycaemia — evidence for the importance of β-adrenergic stimulation. Diabetologia. 30(9). 691–697. 18 indexed citations
18.
Lager, I., H. von Schenck, & Ulf Smith. (1985). Glucagon release and glucose counter-regulation during hypoglycaemia. European Journal of Endocrinology. 110(1). 107–113. 4 indexed citations
19.
Lager, I., et al.. (1983). Reversal of insulin resistance in type I diabetes after treatment with continuous subcutaneous insulin infusion.. BMJ. 287(6406). 1661–1664. 70 indexed citations
20.
Smith, Ulf, et al.. (1980). Can insulin-treated diabetics be given beta-adrenergic-blocking drugs?. BMJ. 281(6248). 1143.2–1144. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Nattrass Breakdown of academic impact, for papers by J. Fowelin Breakdown of academic impact, for papers by James M. Falko Breakdown of academic impact, for papers by Theodora Temelkova‐Kurktschiev Breakdown of academic impact, for papers by M. Oleggini Breakdown of academic impact, for papers by L Graziadei Breakdown of academic impact, for papers by R.J. Heine Breakdown of academic impact, for papers by Jan Lysgaard Madsen Breakdown of academic impact, for papers by Ralph A. DeFronzo Breakdown of academic impact, for papers by Elizabeth B. Rappaport
Rankless by CCL
2026